Contemporary approaches for nonviral gene therapy

Discovery Medicine

Volumn 19, Issue 107, 2015, Pages 447-454

  Jones, Charles H ^a   Hill, Andrew ^b   Chen, Mingfu ^a   Pfeifer, Blaine A ^a  

^a State University of New York   (United States)

^b The University of Texas at Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; PLASMID DNA; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; VIRUS VECTOR; ZINC FINGER PROTEIN;

ARTICLE; CYTOTOXICITY; DNA MODIFICATION; GENE DISRUPTION; GENE EXPRESSION; GENE INSERTION; GENE TARGETING; GENETIC ENGINEERING; HUMAN; IMMUNOGENICITY; NONVIRAL GENE THERAPY; VACCINATION; ANIMAL; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; PROCEDURES; THERAPEUTIC USE;

ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS;

EID: 84940506862     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Acevedo R, Fernandez S, Zayas C, Acosta A, Sarmiento ME, Ferro VA, Rosenqvist E, Campa C, Cardoso D, Garcia L, Perez JL. Bacterial outer membrane vesicles and vaccine applications. Front Immunol 5:121, 2014.
2. Akin D, Sturgis J, Ragheb K, Sherman D, Burkholder K, Robinson JP, Bhunia AK, Mohammed S, Bashir R. Bacteria-mediated delivery of nanoparticles and cargo into cells. Nat Nanotechnol 2(7):441-449, 2007.
3. Avila-Calderon ED, Araiza-Villanueva MG, Cancino-Diaz JC, Lopez-Villegas EO, Sriranganathan N, Boyle SM, Contreras-Rodriguez A. Roles of bacterial membrane vesicles. Arch Microbiol 197(1):1-10, 2015.
4. Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 17(3):253-263, 2006.
5. Bechler SL, Lynn DM. Characterization of degradable polyelectrolyte multilayers fabricated using DNA and a fluorescently-labeled poly(beta-amino ester): shedding light on the role of the cationic polymer in promoting surface-mediated gene delivery. Biomacromolecules 13(2):542-552, 2012.
6. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326(5959):1509-1512, 2009.
7. Chart H, Smith HR, La Ragione RM, Woodward MJ. An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5alpha and EQ1. J Appl Microbiol 89(6):1048-1058, 2000.
8. Chen ZY, He CY, Ehrhardt A, Kay MA. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 8(3):495-500, 2003.
9. Cheung W, Kotzamanis G, Abdulrazzak H, Goussard S, Kaname T, Kotsinas A, Gorgoulis VG, Grillot-Courvalin C, Huxley C. Bacterial delivery of large intact genomic-DNA-containing BACs into mammalian cells. Bioeng Bugs 3(2):86-92, 2012.
10. Cho SW, Kim S, Kim JM, Kim JS. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31(3):230-232, 2013.
11. Critchley-Thorne RJ, Stagg AJ, Vassaux G. Recombinant Escherichia coli expressing invasin targets the Peyer's patches: the basis for a bacterial formulation for oral vaccination. Mol Ther 14(2):183-191, 2006.
12. Critchley RJ, Jezzard S, Vassaux G. Genetically engineered E. coli as a protein delivery vehicle for killing cancer cells. Discov Med 4(22):194-197, 2004.
13. Demuth PC, Min Y, Huang B, Kramer JA, Miller AD, Barouch DH, Hammond PT, Irvine DJ. Polymer multilayer tattooing for enhanced DNA vaccination. Nat Mater 12(4):367-376, 2013.
14. Dietz WM, Skinner NE, Hamilton SE, Jund MD, Heitfeld SM, Litterman AJ, Hwu P, Chen ZY, Salazar AM, Ohlfest JR, Blazar BR, Pennell CA, Osborn MJ. Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses. Mol Ther 21(8):1526-1535, 2013.
15. Farboud B, Meyer BJ. Dramatic Enhancement of Genome Editing by CRISPR/Cas9 Through Improved Guide RNA Design. Genetics 199(4):959-971, 2015.
16. Flessner RM, Jewell CM, Anderson DG, Lynn DM. Degradable polyelectrolyte multilayers that promote the release of siRNA. Langmuir 27(12):7868-7876, 2011.
17. Grillot-Courvalin C, Goussard S, Courvalin P. Wild-type intracellular bacteria deliver DNA into mammalian cells. Cell Microbiol 4(3):177-186, 2002.
18. Gujrati V, Kim S, Kim S-H, Min JJ, Choy HE, Kim SC, Jon S. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. ACS Nano 8(2):1525-1537, 2014.
19. He Y, Nie Y, Cheng G, Xie L, Shen Y, Gu Z. Viral mimicking ternary polyplexes: a reduction-controlled hierarchical unpacking vector for gene delivery. Adv Mater 26(10):1534-1540, 2014.
20. Jones CH, Chen CK, Chen M, Ravikrishnan A, Zhang H, Gollakota A, Chung T, Cheng C, Pfeifer BA. PEGylated cationic polylactides for hybrid biosynthetic gene delivery. Mol Pharm 12(3):846-856, 2015.
21. Jones CH, Chen CK, Ravikrishnan A, Rane S, Pfeifer BA. Overcoming Nonviral Gene Delivery Barriers: Perspective and Future. Mol Pharm 10(11):4082-4098, 2013a.
22. Jones CH, Hakansson AP, Pfeifer BA. Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design. J Mater Chem B 2(46):8053-8068, 2014a.
23. Jones CH, Rane S, Patt E, Ravikrishnan A, Chen CK, Cheng C, Pfeifer BA. Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicity. Mol Pharm 10(11):4301-4308, 2013b.
24. Jones CH, Ravikrishnan A, Chen M, Reddinger R, Kamal Ahmadi M, Rane S, Hakansson AP, Pfeifer BA. Hybrid biosynthetic gene therapy vector development and dual engineering capacity. Proc Natl Acad Sci U S A 111(34):12360-12365, 2014b.
25. Kang S, Lu K, Leelawattanachai J, Hu X, Park S, Park T, Min IM, Jin MM. Virus-mimetic polyplex particles for systemic and inflammation-specific targeted delivery of large genetic contents. Gene Ther 20(11):1042-1052, 2013.
26. Kay MA, He CY, Chen ZY. A robust system for production of minicircle DNA vectors. Nat Biotechnol 28(12):1287-1289, 2010.
27. Keeney M, Ong SG, Padilla A, Yao Z, Goodman S, Wu JC, Yang F. Development of poly(beta-amino ester)-based biodegradable nanoparticles for nonviral delivery of minicircle DNA. ACS Nano 7(8):7241-7250, 2013.
28. Khatri N, Rathi M, Baradia D, Trehan S, Misra A. In vivo delivery aspects of miRNA, shRNA and siRNA. Crit Rev Ther Drug Carrier Syst 29(6):487-527, 2012.
29. Kruhn A, Wang A, Fruehauf JH, Lage H. Delivery of short hairpin RNAs by transkingdom RNA interference modulates the classical ABCB1-mediated multidrug-resistant phenotype of cancer cells. Cell Cycle 8(20):3349-3354, 2009.
30. Laner A, Goussard S, Ramalho AS, Schwarz T, Amaral MD, Courvalin P, Schindelhauer D, Grillot-Courvalin C. Bacterial transfer of large functional genomic DNA into human cells. Gene Ther 12(21):1559-1572, 2005.
31. Larsen MD, Griesenbach U, Goussard S, Gruenert DC, Geddes DM, Scheule RK, Cheng SH, Courvalin P, Grillot-Courvalin C, Alton EW. Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli. Gene Ther 15(6):434-442, 2008.
32. Lee ES, Kim D, Youn YS, Oh KT, Bae YH. A virus-mimetic nanogel vehicle. Angew Chem Int Ed Engl 47(13):2418-2421, 2008.
33. Li L, Puhl S, Meinel L, Germershaus O. Silk fibroin layer-by-layer microcapsules for localized gene delivery. Biomaterials 35(27):7929-7939, 2014.
34. Lu J, Zhang F, Kay MA. A Mini-intronic Plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro. Mol Ther 21(5):954-963, 2013.
35. Lu J, Zhang F, Xu S, Fire AZ, Kay MA. The extragenic spacer length between the 5′ and 3′ ends of the transgene expression cassette affects transgene silencing from plasmid-based vectors. Mol Ther 20(11):2111-2119, 2012.
36. Mali P, Yang L, Esvelt KM, Aach J, Guell M, Dicarlo JE, Norville JE, Church GM. RNA-guided human genome engineering via Cas9. Science 339(6121):823-826, 2013.
37. Miller AD. Delivery of RNAi therapeutics: work in progress. Expert Rev Med Devices 10(6):781-811, 2013.
38. Moore R, Spinhirne A, Lai MJ, Preisser S, Li Y, Kang T, Bleris L. CRISPR-based self-cleaving mechanism for controllable gene delivery in human cells. Nucleic Acids Res 43(2):1297-1303, 2015.
39. Moscou MJ, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors. Science 326(5959):1501, 2009.
40. Musacchio T, Torchilin VP. siRNA delivery: from basics to therapeutic applications. Front Biosci (Landmark Ed) 18:58-79, 2013.
41. Nayerossadat N, Maedeh T, Ali PA. Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 1:27, 2012.
42. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov 4(7):581-593, 2005.
43. Parsa S, Wang Y, Fuller J, Langer R, Pfeifer BA. A comparison between polymeric microsphere and bacterial vectors for macrophage p388d1 gene delivery. Pharm Res 25:1202-1208, 2008a.
44. Parsa S, Wang Y, Rines K, Pfeifer BA. A high-throughput comparison of recombinant gene expression parameters for E. coli-mediated gene transfer to P388D1 macrophage cells. J Biotechnol 137(1-4):59-64, 2008b.
45. Paukner S, Kudela P, Kohl G, Schlapp T, Friedrichs S, Lubitz W. DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages. Mol Ther 11(2):215-223, 2005.
46. Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154(6):1380-1389, 2013.
47. Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11(8):783-784, 2014.
48. Santos JL, Nouri A, Fernandes T, Rodrigues J, Tomas H. Gene delivery using biodegradable polyelectrolyte microcapsules prepared through the layer-by-layer technique. Biotechnol Prog 28(4):1088-1094, 2012.
49. Saurer EM, Flessner RM, Sullivan SP, Prausnitz MR, Lynn DM. Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin. Biomacromolecules 11(11):3136-3143, 2010.
50. Schaffner W. Direct transfer of cloned genes from bacteria to mammalian cells. Proc Natl Acad Sci U S A 77(4):2163-2167, 1980.
51. Schlenk F, Grund S, Fischer D. Recent developments and perspectives on gene therapy using synthetic vectors. Ther Deliv 4(1):95-113, 2013.
52. Seow Y, Wood MJ. Biological gene delivery vehicles: beyond viral vectors. Mol Ther 17(5):767-777, 2009.
53. Unal CM, Schaar V, Riesbeck K. Bacterial outer membrane vesicles in disease and preventive medicine. Semin Immunopathol 33(5):395-408, 2011.
54. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11(9):636-646, 2010.
55. Vilte DA, Larzabal M, Mayr UB, Garbaccio S, Gammella M, Rabinovitz BC, Delgado F, Meikle V, Cantet RJ, Lubitz P, Lubitz W, Cataldi A, Mercado EC. A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts (BGs) reduces the excretion of E. coli O157:H7 in calves. Vet Immunol Immunopathol 146(2):169-176, 2012.
56. Xiang S, Fruehauf J, Li CJ. Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat Biotechnol 24(6):697-702, 2006.
57. Xu DQ, Zhang L, Kopecko DJ, Gao L, Shao Y, Guo B, Zhao L. Bacterial delivery of siRNAs: a new approach to solid tumor therapy. Methods Mol Biol 487:161-187, 2009.
58. Xu J, Luft JC, Yi X, Tian S, Owens G, Wang J, Johnson A, Berglund P, Smith J, Napier ME, Desimone JM. RNA replicon delivery via lipid-complexed PRINT protein particles. Mol Pharm 10(9):3366-3374, 2013.
59. Xu L, Frederik P, Pirollo KF, Tang WH, Rait A, Xiang LM, Huang W, Cruz I, Yin Y, Chang EH. Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery. Hum Gene Ther 13(3):469-481, 2002.
60. Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. Non-viral vectors for gene-based therapy. Nat Rev Genet 15(8):541-555, 2014.
61. Zou Y, Xie L, Carroll S, Muniz M, Gibson H, Wei WZ, Liu H, Mao G. Layer-by-layer films with bioreducible and nonbioreducible polycations for sequential DNA release. Biomacromolecules 15(11):3965-3975, 2014.